Location: Home
  • search
  • go
  • Relate News
  • 3/10/2021I-Mab Signs Two New Partnerships to Expand Transformational I/O Pip...
  • 3/10/2021ReForm Biologics Announces the Issuance of Chinese Patent for Therapeu...
  • 3/10/2021Multi-source Financing for Tuberculosis Treatment in China: Key Issues...
  • 3/10/2021I-Mab BioPharma and Its Dual Drug Portfolio
  • 3/9/2021Sinopharm Faces Battle to Turn Covid Vaccine into a Global Success
  • 3/9/2021CNIPA Releases Chinese IP Related Statistics in 2020
  • 3/9/2021NHSA Holds Conference, Highlighting Path Forward for Centralized Drug ...
  • 3/8/2021Sorrento's Socazolimab Cleared for Late-Stage Lung Cancer Study in Chi...
  • 3/8/2021CDMO Vetter Opens Office in China to Meet Growing Demands
  • 3/8/2021Winhealth and Merz Collaborate Enter Distribution Pact for Liver Dise...
  • 3/8/2021CStone Forges Strategic Alliance with Sinopharm for Commercialization ...
  • 3/8/2021Eli Lilly Launches Verzenio (Abemaciclib) in China
  • 3/8/2021FT: Pharma Groups Spend Billions to Tap into Booming China Healthcare
  • 3/5/2021Junshi Initiates Toripalimab Rolling BLA Submission for Nasopharyngeal...
  • 3/5/2021Premier Delivers Government Work Report at the NPC Session (with Summa...
  • 3/5/2021Recent Executive Moves
  • 3/4/2021GSK Granted Approval for 2nd Indication of Lamictal Dispersible Tablet...
  • 3/4/2021NHC: China Achieves Phased Success with Its Tiered Medical System Buil...
  • 3/4/2021DSM Wins Patent Case against China’s Anhui Tiger Vitamin
  • 3/4/2021Amgen Buys Five Prime to Expand in Asia-Pacific’s Oncology Market
  • 3/4/2021Abcam Expands in China to Meet Increased Demand of BioPharma Sector
  • 3/4/2021Antitrust in China – 2020 Year in Review
  • 3/3/2021 Innoforce and dMed Collaborate to Accelerate the Development of Innov...
  • 3/3/2021Merck and Guangzhou Pharma Sign MOU for Alliance in GD-HK-Macao Greate...
  • 3/3/2021NMPA Revises Packages Inserts of Tramadol Injection and Single-ingredi...
  • 3/3/2021Sun Pharma's NDA for Odomzo (Sonidegib) to be Granted Priority Review
  • 3/3/2021ADC Developer Suzhou Medilink Therapeutics Secures $50M in A1 Financin...
  • 3/2/2021ADC Developer Suzhou Medilink Therapeutics Secures $50M in A1 Financin...
  • 3/2/2021NMPA Withdraws Approvals of 226 Drug Products Including 12 MNC Product...
  • 3/2/2021WuXi AppTec Completes Acquisition of Gene Therapy CRDO OXGENE
  • Page:95/357 Total number of articles:10684: [First][<<] [93] [94] [95] [96] [97] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group